Sun Pharma’s phase 3 clinical studies evaluating ILUMYA in active psoriatic arthritis met their primary endpoint Read more
FDA approves 127 innovator and biosimilar drugs in 2024, marks shift in pharma approval landscape Read more
Miltenyi Biotec and THSTI launch India’s first hands-on clinical cell manufacturing training programme Read more
CORONA Remedies acquires seven Bayer India brands to expand cardiology and women’s health portfolio Read more